# Onpattro

NDC: 71336-1000
Generic name: patisiran
Labeler / Manufacturer: Alnylam Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, LIPID COMPLEX
Routes: INTRAVENOUS
Marketing started: 20180813

FDA application: NDA210922

## Active ingredients

- PATISIRAN SODIUM: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71336-1000"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71336-1000
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e87ec36f-b4b4-49d4-aea4-d4ffb09b0970
